Association For Accessible Medicines is located in Washington, DC. The organization was established in 2000. According to its NTEE Classification (S41) the organization is classified as: Chambers of Commerce & Business Leagues, under the broad grouping of Community Improvement & Capacity Building and related organizations. As of 12/2022, Association For Accessible Medicines employed 36 individuals. This organization is an independent organization and not affiliated with a larger national or regional group of organizations. Association For Accessible Medicines is a 501(c)(6) and as such, is described as a "Business League, Chambers of Commerce, or Real Estate Board" by the IRS.
For the year ending 12/2022, Association For Accessible Medicines generated $22.7m in total revenue. This represents relatively stable growth, over the past 8 years the organization has increased revenue by an average of 4.1% each year. All expenses for the organization totaled $24.9m during the year ending 12/2022. While expenses have increased by 8.4% per year over the past 8 years. They've been increasing with an increasing level of total revenue. You can explore the organizations financials more deeply in the financial statements section below.
Since 2014, Association For Accessible Medicines has awarded 189 individual grants totaling $3,122,660. If you would like to learn more about the grant giving history of this organization, scroll down to the grant profile section of this page.
Form
990
Mission & Program ActivityExcerpts From the 990 Filing
TAX YEAR
2022
Describe the Organization's Mission:
Part 3 - Line 1
PROMOTE THE INTEREST OF THE GENERIC PHARMACEUTICAL AND BIOSIMILAR INDUSTRY.
Describe the Organization's Program Activity:
Part 3 - Line 4a
GOVERNMENT AFFAIRS - ADVOCATE ON BEHALF OF THE GENERIC PHARMACEUTICAL AND BIOSIMILARS INDUSTRY WITH RESPECT TO FEDERAL, STATE, AND MUNICIPAL RULES, LAWS, AND ORDERS AFFECTING THE INDUSTRY.
POLICY & STRATEGIC ALLIANCES - IDENTIFY POLICY ISSUES AFFECTING THE GENERIC DRUG AND BIOSIMILARS INDUSTRIES AND FACILITATE DEVELOPMENT OF POLICY POSITIONS AMONG OUR MEMBER COMPANIES; WORK WITH THE AGENCIES OF THE U.S. GOVERNMENT, AND STATE AND INTERNATIONAL BODIES TO EDUCATE AND COMMUNICATE POLICY POSITIONS ON STRATEGIC PRIORITIES; DEVELOP DATA TO SUPPORT ADVOCACY INITIATIVES AND PUBLISH WHITE PAPERS, REPORTS AND OTHER POLICY RESOURCES; BUILD RELATIONSHIPS WITH THIRD-PARTY STAKEHOLDERS ACROSS SUPPLY CHAIN, PATIENT, PROVIDER, CONSUMER, AND OTHER SECTORS TO SUPPORT ADVOCACY INITIATIVES.
COMMUNICATIONS & MARKETING - EDUCATING POLICYMAKERS, MEDIA, PATIENTS AND OTHER STAKEHOLDERS ABOUT THE ECONOMIC AND THERAPEUTIC CONTRIBUTIONS OF GENERIC AND BIOSIMILARS MEDICINES AS WELL AS THEIR SAFETY AND EFFICACY; PRODUCING AND SHARING PATIENT AND TAXPAYER SAVINGS DATA AND STORIES OF PATIENTS WHOSE HEALTH IS SAVED, IMPROVED AND MAINTAINED BY GENERIC AND BIOSIMILARS MEDICINES; DISSEMINATING INSTRUCTIONAL MATERIALS AND CURRICULUM TO PROMOTE THE SAFE USE, STORAGE AND DISPOSAL OF PRESCRIPTION MEDICINES.
Name (title) | Role | Hours | Compensation |
---|---|---|---|
Patel Chirag Chair | OfficerTrustee | 2 | $0 |
Baeder Christine Vice Chair | OfficerTrustee | 2 | $0 |
Hoffmann Brian Treasurer Oct-Dec | OfficerTrustee | 2 | $0 |
Hampton Jeff Director | Trustee | 2 | $0 |
Diolosa Paul Director | Trustee | 2 | $0 |
Dischner Dan Director | Trustee | 2 | $0 |
Vendor Name (Service) | Service Year | Compensation |
---|---|---|
Firehouse Strategies Consulting Services | 12/30/22 | $627,000 |
Kirkland & Ellis Legal Services | 12/30/22 | $620,433 |
Avalere Health Analytic Services | 12/30/22 | $544,000 |
Model B Digital Strategies | 12/30/22 | $495,227 |
Iqvia Inc Research Studies | 12/30/22 | $505,684 |
Statement of Revenue | |
---|---|
Federated campaigns | $0 |
Membership dues | $0 |
Fundraising events | $0 |
Related organizations | $0 |
Government grants | $0 |
All other contributions, gifts, grants, and similar amounts not included above | $0 |
Noncash contributions included in lines 1a–1f | $0 |
Total Revenue from Contributions, Gifts, Grants & Similar | $0 |
Total Program Service Revenue | $22,237,409 |
Investment income | $52,672 |
Tax Exempt Bond Proceeds | $0 |
Royalties | $0 |
Net Rental Income | $390,635 |
Net Gain/Loss on Asset Sales | -$34,014 |
Net Income from Fundraising Events | $0 |
Net Income from Gaming Activities | $0 |
Net Income from Sales of Inventory | $0 |
Miscellaneous Revenue | $0 |
Total Revenue | $22,662,006 |
Statement of Expenses | |
---|---|
Grants and other assistance to domestic organizations and domestic governments. | $275,700 |
Grants and other assistance to domestic individuals. | $0 |
Grants and other assistance to Foreign Orgs/Individuals | $0 |
Benefits paid to or for members | $0 |
Compensation of current officers, directors, key employees. | $3,311,015 |
Compensation of current officers, directors, key employees. | $0 |
Compensation to disqualified persons | $0 |
Other salaries and wages | $6,040,884 |
Pension plan accruals and contributions | $652,294 |
Other employee benefits | $446,826 |
Payroll taxes | $449,152 |
Fees for services: Management | $0 |
Fees for services: Legal | $2,062,207 |
Fees for services: Accounting | $105,975 |
Fees for services: Lobbying | $2,786,667 |
Fees for services: Fundraising | $0 |
Fees for services: Investment Management | $0 |
Fees for services: Other | $3,328,024 |
Advertising and promotion | $881,836 |
Office expenses | $225,448 |
Information technology | $316,847 |
Royalties | $0 |
Occupancy | $1,307,524 |
Travel | $191,664 |
Payments of travel or entertainment expenses for any federal, state, or local public officials | $0 |
Conferences, conventions, and meetings | $998,911 |
Interest | $0 |
Payments to affiliates | $0 |
Depreciation, depletion, and amortization | $280,972 |
Insurance | $52,102 |
All other expenses | $0 |
Total functional expenses | $24,851,441 |
Balance Sheet | |
---|---|
Cash—non-interest-bearing | $9,388,789 |
Savings and temporary cash investments | $6,890,189 |
Pledges and grants receivable | $0 |
Accounts receivable, net | $119,978 |
Loans from Officers, Directors, or Controlling Persons | $0 |
Loans from Disqualified Persons | $0 |
Notes and loans receivable | $0 |
Inventories for sale or use | $0 |
Prepaid expenses and deferred charges | $478,899 |
Net Land, buildings, and equipment | $1,122,516 |
Investments—publicly traded securities | $413,257 |
Investments—other securities | $3,247,147 |
Investments—program-related | $0 |
Intangible assets | $0 |
Other assets | $5,828,445 |
Total assets | $27,489,220 |
Accounts payable and accrued expenses | $1,121,082 |
Grants payable | $0 |
Deferred revenue | $10,696,433 |
Tax-exempt bond liabilities | $0 |
Escrow or custodial account liability | $0 |
Loans and other payables to any current Officer, Director, or Controlling Person | $0 |
Secured mortgages and notes payable | $0 |
Unsecured mortgages and notes payable | $0 |
Other liabilities | $8,462,359 |
Total liabilities | $20,279,874 |
Net assets without donor restrictions | $7,209,346 |
Net assets with donor restrictions | $0 |
Capital stock or trust principal, or current funds | $0 |
Paid-in or capital surplus, or land, building, or equipment fund | $0 |
Retained earnings, endowment, accumulated income, or other funds | $0 |
Total liabilities and net assets/fund balances | $27,489,220 |
Over the last fiscal year, Association For Accessible Medicines has awarded $265,000 in support to 14 organizations.
Grant Recipient | Amount |
---|---|
AFPE PURPOSE: GENERAL CONTRIBUTION | $10,000 |
ALLIANCE FOR RETIRED AMERICANS PURPOSE: GENERAL CONTRIBUTION | $15,000 |
AMERICAN CONSUMER INSTITUTE CCR PURPOSE: GENERAL CONTRIBUTION | $15,000 |
AMERICAN PHARMACISTS ASSOCIATION PURPOSE: GENERAL CONTRIBUTION | $25,000 |
CITIZENS AGAINST GOVERNMENT WASTE PURPOSE: GENERAL CONTRIBUTION | $15,000 |
CONSUMER ACTION PURPOSE: GENERAL CONTRIBUTION | $12,500 |